Crane Company · CR · FY2025 Q4 · Calendar Q1 2026

Crane’s Q4 growth broadens, while integration and chemical-market risks remain

The call presents a growth case built on aerospace, defense, nuclear and pharma demand, alongside recent acquisitions. Whether that translates into improved profitability depends on integrating the acquired businesses and executing cost initiatives while managing chemical-market weakness and higher interest expense.

Reported After market closeNYSEIndustrials $11.45B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.53 Consensus $1.43
EPS surprise +7.0% Reported versus consensus
Reported revenue $581.0M Consensus $571.2M
Revenue surprise +1.7% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -11.5% Event window
SPY move +0.4% Same window
Abnormal move -11.9% Stock minus SPY
Volume 6.0× Versus trailing sessions
Subsequent drift +9.7% Up to 20 sessions
CRSPY benchmark

Ask FN2 about CR FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management reported Q4 core sales growth, discussed four completed acquisitions and announced a CEO transition to Alex Alcala, effective April 27, 2026. It also set 2026 adjusted EPS guidance, with acquisition integration and cost-out execution central to the outlook.

Guidance delta

Management provided 2026 adjusted EPS guidance of $6.55–$6.75, described as 10% year-over-year growth. The supplied analysis does not provide a prior 2026 guidance range for comparison.

Key takeaways

  • Core sales grew 5.4%, with Aerospace & Advanced Technologies and Process Flow Technologies leading.
  • The four recent acquisitions are expected to be slightly accretive to 2026 earnings, according to management.
  • 2026 adjusted EPS guidance is $6.55–$6.75; management described this as 10% year-over-year growth.
  • Management expects integration and cost-out efforts to support margin improvement, while acknowledging near-term integration costs.
  • The outlook draws on aerospace, defense, nuclear and pharma demand, with chemical-market softness a counterpoint.

Management priorities

  • Integrate Druck, Panametrics, Reuter-Stokes and Optek-Danulat into their respective segments.
  • Advance F-16 brake-control production and pursue additional defense programs.
  • Expand nuclear sensing and small modular reactor offerings.
  • Execute organizational simplification, product-line rationalization and lean-operating initiatives.
  • Pursue targeted acquisitions while maintaining capacity for strategic deals.

Follow CR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CR EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $1.24 Q2 '24 actual $1.30, beat Q3 '24 estimate $1.32 Q3 '24 actual $1.38, beat Q2 '25 estimate $1.34 Q2 '25 actual $1.49, beat Q3 '25 estimate $1.49 Q3 '25 actual $1.64, beat Q4 '25 estimate $1.43 Q4 '25 actual $1.53, beat Q1 '26 estimate $1.44 Q1 '26 actual $1.65, beat Q2 '26 estimate $1.68 Q2 '26 actual $1.79, beat Q3 '26 estimate $1.82 Q3 '26 actual $2.05, beat Q4 '26 estimate $1.83 Q1 '27 estimate $1.82 Q2 '27 estimate $1.99 Q3 '27 estimate $2.16
Show 2 more >

Analyst Consensus ?

ConsensusBuy28 ratings
Bullish2175.0%
Neutral725.0%
Bearish00.0%

Analyst 52W Price Targets

$198.02Current
$125Low
$216.6Average
$255High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Stifel Buy BuyMaintainOct 29, 2026
DA Davidson Buy BuyMaintainSep 15, 2026
B of A Securities Buy BuyMaintainAug 21, 2025
UBS Buy BuyMaintainJul 30, 2025
Deutsche Bank Buy BuyMaintainJun 10, 2025
Show 23 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $198.02. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
D.A. DavidsonAnalyst unavailable$255$203.12 +28.8%Oct 29, 2026
Stifel NicolausNathan Jones$247$198.42 +24.7%Oct 29, 2026
Deutsche BankAnalyst unavailable$240$203.81 +21.2%Sep 1, 2026
D.A. DavidsonAnalyst unavailable$245$212.48 +23.7%Jul 30, 2026
Stifel NicolausNathan Jones$242$217.49 +22.2%Jul 20, 2026
See 15 more

Track every rating change on CR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Established in 1855 in Stamford, Connecticut, Crane Company, formerly known as Crane Holdings, Co., is a global industrial manufacturer and distributor of specialized engineered products. Operating across the Americas, Europe, the Middle East, Asia, and Australia, the company is structured into four main business divisions. The Aerospace & Electronics segment provides critical components and integrated systems, including both original equipment and aftermarket parts, primarily to commercial and military aerospace, defense, and space exploration markets. This encompasses products like pressure sensors for aircraft engine control, braking systems for fighter jets, power conversion solutions for spacecraft, and lubrication systems.…

Historical context

All CR earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-11-02T04:30:52.665830+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T04:30:52.662210+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.